ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,631.22
      0.00%
      US Tech 100
      19,891.60
      0.23%
      Dow Jones
      40,211.72
      0.00%
      Brent Oil
      82.945
      -1.65%
      Bitcoin
      63,820.87
      -1.59%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. UK
      5. LSE
      6. Alligator Bioscience Ab (0RK9)

      7. Alligator Bioscience Ab (0RK9) News

      0RK9

      Alligator Bioscience Ab (0RK9)

      Alligator Bioscience Ab
      		Date:
      Sort by:
       Showing the most relevant articles for your search:LSE:0RK9
      DateTimeSourceHeadlineSymbolCompany
      12/30/20207:54AMPR Newswire (US)Alligator Bioscience publishes prospectus in connection with forthcoming rights issueLSE:0RK9Alligator Bioscience Ab
      12/29/20203:25AMPR Newswire (US)Alligator Bioscience recruits new Chief Medical OfficerLSE:0RK9Alligator Bioscience Ab
      12/29/20203:23AMPR Newswire (US)Alligator Bioscience recruits new Chief Medical OfficerLSE:0RK9Alligator Bioscience Ab
      12/28/20205:26AMPR Newswire (US)Alligator Bioscience submits CTA for the mitazalimab Phase II study OPTIMIZE-1LSE:0RK9Alligator Bioscience Ab
      12/28/20205:25AMPR Newswire (US)Alligator Bioscience submits CTA for the mitazalimab Phase II study OPTIMIZE-1LSE:0RK9Alligator Bioscience Ab
      12/10/20202:53AMPR Newswire (US)Alligator Bioscience launches ALLIGATOR-FAB™ - a novel human antibody libraryLSE:0RK9Alligator Bioscience Ab
      12/10/20202:51AMPR Newswire (US)Alligator Bioscience launches ALLIGATOR-FAB™ - a novel human antibody libraryLSE:0RK9Alligator Bioscience Ab
      12/04/20203:20AMPR Newswire (US)Approved IND for Alligator Bioscience's CD40-targeting antibody mitazalimabLSE:0RK9Alligator Bioscience Ab
      12/04/20203:18AMPR Newswire (US)Approved IND for Alligator Bioscience's CD40-targeting antibody mitazalimabLSE:0RK9Alligator Bioscience Ab
      11/16/20208:18AMPR Newswire (US)Aptevo Therapeutics and Alligator Bioscience advancing the bispecific 4-1BBx5T4 antibody ALG.APV-527 into Phase I clinical de...LSE:0RK9Alligator Bioscience Ab
      11/16/20208:16AMPR Newswire (US)Aptevo Therapeutics and Alligator Bioscience advancing the bispecific 4-1BBx5T4 antibody ALG.APV-527 into Phase I clinical de...LSE:0RK9Alligator Bioscience Ab
      11/09/20208:15AMPR Newswire (US)Alligator Bioscience presents at the SITC 35th Annual MeetingLSE:0RK9Alligator Bioscience Ab
      11/09/20208:12AMPR Newswire (US)Alligator Bioscience presents at the SITC 35th Annual MeetingLSE:0RK9Alligator Bioscience Ab
      11/05/20202:56AMPR Newswire (US)Alligator Bioscience presents the CD40 antibody mitazalimab at the World Immunotherapy Congress 2020LSE:0RK9Alligator Bioscience Ab
      11/05/20202:49AMPR Newswire (US)Alligator Bioscience presents the CD40 antibody mitazalimab at the World Immunotherapy Congress 2020LSE:0RK9Alligator Bioscience Ab
      10/27/20209:18AMPR Newswire (US)Predicted therapeutic range dose levels reached in ATOR-1017 Phase ILSE:0RK9Alligator Bioscience Ab
      10/27/20209:16AMPR Newswire (US)Predicted therapeutic range dose levels reached in ATOR-1017 Phase ILSE:0RK9Alligator Bioscience Ab
      10/22/20202:30AMPR Newswire (US)Alligator Bioscience AB (publ): Interim report January-September 2020LSE:0RK9Alligator Bioscience Ab
      10/22/20202:28AMPR Newswire (US)Alligator Bioscience AB (publ): Interim report January-September 2020LSE:0RK9Alligator Bioscience Ab
      10/22/20201:25AMPR Newswire (US)Alligator Bioscience focuses on ATOR-1017 and mitazalimabLSE:0RK9Alligator Bioscience Ab
      10/22/20201:23AMPR Newswire (US)Alligator Bioscience focuses on ATOR-1017 and mitazalimabLSE:0RK9Alligator Bioscience Ab
      09/28/20207:25AMPR Newswire (US)Alligator Bioscience appoints Gayle Mills as Chief Business OfficerLSE:0RK9Alligator Bioscience Ab
      09/28/20207:24AMPR Newswire (US)Alligator Bioscience appoints Gayle Mills as Chief Business OfficerLSE:0RK9Alligator Bioscience Ab
      09/24/202011:00AMPR Newswire (US)Alligator Bioscience launches a new immuno-oncology conceptLSE:0RK9Alligator Bioscience Ab
      09/24/202010:58AMPR Newswire (US)Alligator Bioscience launches a new immuno-oncology conceptLSE:0RK9Alligator Bioscience Ab
      09/16/20202:40AMPR Newswire (US)Alligator Bioscience receives patent approval for the drug candidate ATOR-1015LSE:0RK9Alligator Bioscience Ab
      09/16/20202:39AMPR Newswire (US)Alligator Bioscience receives patent approval for the drug candidate ATOR-1015LSE:0RK9Alligator Bioscience Ab
      09/09/20208:19AMPR Newswire (US)Alligator Bioscience presents an update regarding the Phase I study with the drug candidate ATOR-1015LSE:0RK9Alligator Bioscience Ab
      09/09/20208:17AMPR Newswire (US)Alligator Bioscience presents an update regarding the Phase I study with the drug candidate ATOR-1015LSE:0RK9Alligator Bioscience Ab
      09/04/20202:42AMPR Newswire (US)Alligator Bioscience presents positive biomarker data demonstrating proof of mechanism in mitazalimab clinical Phase I studyLSE:0RK9Alligator Bioscience Ab
       Showing the most relevant articles for your search:LSE:0RK9